Profile
Atul Mukund Deshpande worked as an Associate Director at Sanofi, Inc. (China) from 2012 to 2014 and as an Executive Director & Chief Strategy Officer at HBM Holdings Ltd.
from 2018 to 2021.
He earned a doctorate degree from the University of California, Irvine in 2007, an MBA from Cranfield University in 2011, and an undergraduate degree from the University of Mumbai in 2000.
Former positions of Atul Mukund Deshpande
| Companies | Position | End |
|---|---|---|
| HBM HOLDINGS LIMITED | Director/Board Member | 24/04/2021 |
Sanofi, Inc. (China)
 Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Corporate Officer/Principal | 30/11/2014 |
Training of Atul Mukund Deshpande
| University of Mumbai | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| Cranfield University | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Sanofi, Inc. (China)
Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Atul Mukund Deshpande
